Snu S Spacemetadata only
Tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the Asian subgroup of the RATIONALE-305 study
quality-of-life, cancer, qlq-c30, gastric cancer, esophagogastric junction, health-related quality of life, immunotherapy, patient-reported outcomes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 431806
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.